Elementis: An Attractive Specialty Chemicals Company At A 7% FCF Yield

Jan. 28, 2024 11:40 AM ETElementis plc (ELMTY) Stock, EMNSF Stock6 Comments

Summary

  • Elementis is a specialty chemicals company focusing on personal healthcare and coatings, with a market capitalization of approximately $1.05B.
  • The company's free cash flow profile is strong, with an underlying free cash flow per share of approximately $0.056 or 4.4 pence in the first semester of last year.
  • Elementis expects to report an operating profit of $102-104M in 2023 and aims to achieve a full-year revenue of $800M and an operating margin of 19% in the future.
  • Looking for a helping hand in the market? Members of European Small-Cap Ideas get exclusive ideas and guidance to navigate any climate. Learn More »
America"s Most Beautiful Underarms Contest

Mario Tama/Getty Images News

Introduction

Elementis (OTCPK:ELMTY) (OTCPK:EMNSF) is a specialty chemicals company with a worldwide presence. The company had to reinvent itself in the past few years and is now predominantly focusing on personal healthcare and coatings. The company supplies

Consider joining European Small-Cap Ideas to gain exclusive access to actionable research on appealing Europe-focused investment opportunities, and to the real-time chat function to discuss ideas with similar-minded investors!

This article was written by

The Investment Doctor profile picture
21.25K Followers

The Investment Doctor is a financial writer, highlighting European small-caps with a 5-7 year investment horizon. He strongly believes a portfolio should consist of a mixture of dividend and growth stocks.

He is the leader of the investment group European Small Cap Ideas which offers exclusive access to actionable research on appealing Europe-focused investment opportunities not found elsewhere. The a focus is on high-quality ideas in the small-cap space, with emphasis on capital gains and dividend income for continuous cash flow. Features include: two model portfolios - the European Small Cap Ideas portfolio and the European REIT Portfolio, weekly updates, educational content to learn more about the European investing opportunities, and an active chat room to discuss the latest developments of the portfolio holdings. Learn more.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of EMNSF either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About ELMTY Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Prev. Close
Compare to Peers

More on ELMTY

Related Stocks

SymbolLast Price% Chg
EMNSF
--
ELMTY
--